Archive for the ‘Viruses’ Category

New Study: The Hidden Ways Microbes Control Tick Behavior

https://rawlsmd.com/health-articles/new-study-the-hidden-ways-microbes-control-tick-behavior?

New Study: The Hidden Ways Microbes Control Tick Behavior

New Study: The Hidden Ways Microbes Control Tick Behavior

by Jenny Lelwica Buttaccio
Posted 9/17/20

We’ve heard a lot of late about an increase in Lyme disease cases, but tick-borne diseases of all kinds — including babesiosis, anaplasmosis, rickettsiosis, and others — are on the rise throughout the United States, reports the Centers for Disease Control and Prevention (CDC). At least part of the increase in tick-borne illnesses can be traced to an expanding tick population, caused by several factors including changes in climate patterns and the development of housing into wooded areas, creating closer interactions between people, animals, and ticks.

But what if there’s also an unseen force at work compelling ticks to act out or present with certain behaviors that give them a leg up when it comes to their own survival — and that of the microbes they carry? New research suggests that perhaps there’s more to this story than we know.

First, a Basic Overview of Ticks On the Hunt

More than four decades after the first cases of Lyme disease were diagnosed, we’re still learning about tick behavior and why they operate in the way they do. We know that blood hosts like humans and animals are critical for tick survival, so ticks are regularly on the prowl.

A tick’s vision isn’t very good, so they rely on other sensory components to find food sources. Located on the first pairs of ticks’ legs are tiny structures called Haller’s organs. These organs are found only on ticks, and it is believed that they function somewhat like antennae and utilize the sense of smell to detect odors wafting through the air to find unsuspecting hosts.

Using their Haller’s organs, ticks detect the carbon dioxide (CO2) that comes from human respiration and breathing — they can sense other chemicals like ammonia and pheromones, too. While certain ticks, like the Lone Star tick, can aggressively charge potential human hosts, most prefer a more subtle approach: Waiting patiently on blades of grass or areas of brush until you approach them, an activity known as “questing.”

diagram of tick biology

When a tick quests, they grip the blade of grass or brush with their back legs and stretch their front legs into the air. In due time, a human or animal walks past, and they latch on, using the front legs to ascend their new host and search for a suitable spot to begin feeding.

As weird and as sci-fi as all this sounds, emerging research from Giovanni Benelli, PhD, Senior Research Entomologist at the University of Pisa in Pisa, Italy, has begun to shed light on microscopic agents that exert influence upon ticks’ hunting behavior. Interestingly, it’s the very microbes we work so hard to avoid that play puppeteer to their tick hosts.

6 Microbes that Manipulate Tick Behavior

In August 2020, Benelli published a new review in the journal Pathogens investigating whether microbes Anaplasma, Borrelia, Babesia, Bartonella, Rickettsia, and tick-borne encephalitis virus (TBEV) were involved in influencing tick behavior and adaptive significance (traits that affect a tick’s reproductive success). Pathogenic manipulation — such as an increase in biting frequency and duration and changing host-borne odors to make them more appealing meals for other arthropods like mosquitos and sand flies — has already been noted in scientific literature.

In regards to ticks, Bellini’s data suggests modes of pathogen-tick manipulation may include physiological changes, tolerance to extreme temperatures, and enhanced survivability, among others. Here, we’ll take a look at some of the key highlights of Benelli’s research, a wealth of further insights into tick behavior that could be a crucial factor in helping to curtail the bugs’ proliferation and their ability to spread chronic illnesses.

1. How Borrelia Impacts Tick Behavior

Borrelia is the bacteria implicated in Lyme disease. In the United States, Borrelia burgdorferi is the species that’s found in black-legged ticks (Ixodes scapularis) or deer ticks. However, in Europe, the predominant Lyme disease-carrying tick is the castor bean tick (Ixodes ricinus).

Borrelia infection in the blood. Borrelia bacteria cause borreliose, transmitted by ticks and by lice.

Borrelia may manipulate tick behavior in both tick species, according to Bellini’s review. Here are some of his key findings:

Key Findings:

  • Black-legged nymph ticks infected with B. burgdorferi showed enhanced movement toward or away from light sources (phototaxis).
  • Nymph ticks infected with B. burgdorferi demonstrated an affinity for vertical surfaces such as the top layers of leaf litter piles or plant vegetation like blades of grass, which may provide them with more opportunities to come into contact with hosts.
  • B. burgdorferi stimulated tick histamine release factor (tHRF), the chemical that regulates vascular permeability and improves blood flow to the site of the bite for feeding.
  • Infected adult black-legged ticks had slower mobility than their non-infected counterparts. However, research is unclear whether this is a behavior adaptation resulting from B. burgdorferi.
  • Castor bean nymph ticks exposed to extremely dry conditions showed they were more active and more resistant to harsh conditions than those that were not carrying the pathogen.
  • Nymph ticks carrying a strain of Borrelia known as Borrelia afzelii (a European strain known for its ability to affect the central nervous system) had increased rates of mobility, including duration and speed of movement, over non-infected ones.

The Takeaway

Indeed B. burgdorferi may manipulate tick behavior in several ways, but Bellini acknowledges that further research is needed to determine how these behaviors contribute to disease and how the data can be used to slow the spread of ticks and prevent the transmission of Lyme disease.

2. How Anaplasma Affects Tick Behavior

All ticks, including the black-legged tick, carry multiple disease-causing microbes known as coinfections. One such microbe is Anaplasma phagocytophilum, previously called human granulocytic ehrlichiosis (HGE). When a tick is infected with A. phagocytophilum, it may demonstrate behavioral changes that influence survival, questing, and feeding.

Anaplasma microbe, microscope view

The following three are important points to note from Bellini’s research:

Key Findings

  • A. phagocytophilum-infected black-legged ticks create heat shock proteins in response to stressful environmental circumstances. This makes them more resilient to extremely dry environments and boosts their survivability rates.
  • In the non-infected tick population, cold temperatures can raise the tick mortality rate. But ticks that have been infected with A. phagocytophilum have an advantage — they manufacture an antifreeze glycoprotein that guards them against the cold.
  • A. phagocytophilum is present in the salivary glands of ticks, and it inhibits cellular death to allow for the infection to be transmitted from the tick’s vector to the host, fostering more effective feeding and greater survival.

The Takeaway

The relationship between A. phagocytophilum and tick manipulation is a better-researched interaction than that of other ticks and pathogens. The mechanisms by which A. phagocytophilum alters the behavior of the tick are more apparent in terms of how it augments tick reproduction and survivability. However, when it comes to other species of Anaplasma that may impact humans or animals, more research is needed.

3. How Babesia Affects Tick Behavior

Babesia is a distant cousin of malaria and a less virulent microbe, comparatively. Babesia may occur in up to 40% of people infected with Lyme disease, indicates a report in Trends in Parasitology, making it a relatively common coinfection. The species of Babesia that are most likely to pose a disease risk to humans are Babesia microti, Babesia divergins, and Babesia ducani (WA-1).

Babesia microbe, zoomed view, round

Regarding Benelli’s review, only a few studies have looked at the effects Babesia may have on tick behavior, but he noted the following:

Key Findings

  • B. microti maximized the success of feeding and strengthened the survival of shrew ticks (Ixodes trianguliceps), but these modifications didn’t correlate with the strain’s infection rates.
  • In animal studies, B microti delayed the amount of time it took for a tick to become engorged.
  • Nymph ticks that fed on infected hosts had a higher body weight than those that fed on non-infected ones.
  • Larvae who fed on infected hosts shed their skin more quickly (a process known as molting) than those that fed on non-infected ones.

The Takeaway

At present, the research on Babesia species and their ability to manipulate tick behavior is scant. The processes that encourage feeding, development, and the survival of ticks infected with Babesia have yet to be determined.

4 & 5. How Bartonella and Rickettsia Affect Tick Behavior

Rickettsia microbe, zoomed in microscope view

Although Bartonella, a common coinfection found in people with Lyme, and Rickettsia, a highly virulent and life-threatening microbe, can pose serious health risks to humans, little is known about the behavioral changes these infections may have on tick behavior. A few points worthy of consideration include:

Key Findings

  • Bartonella-infected castor bean ticks had an increase in a component called Ixodes ricinusserine protease inhibitor (IrSPI). This enzyme inhibitor is involved in such biological processes as inflammation, blood clotting, wound healing, constricting blood vessels, and altering hosts’ defense systems.
  • Rickettsia-infected ticks demonstrated a greater inclination towards electromagnetic fields than non-infected ones.

The Takeaway

Like Babesia, the research on Bartonella- and Rickettsia-infected ticks is minimal. However, because annual incidences are on the rise, continued investigation in this area has the potential to bring about crucial information for the benefit of public health.

6. How Tick-Borne Encephalitis Virus Affects Tick Behavior

Tick-borne encephalitis (TBEV) is a viral infection spread through the bite of an infected tick. The virus resides throughout Europe and Asia, according to the CDC, making the infection relatively unknown in the U.S.

Encephalitis microbe, zoomed in microscope view

Between 20% and 30% of people who acquire the infection develop symptoms that affect the nervous system. Evidence for two hypotheses suggest the virus can manipulate tick behavior in the following ways:

Key Findings

  • TBEV intensifies tick movement and the ability to find a host.
    Feeding results in higher concentrations of TBEV.
  • When a TBEV-infected tick is unfed, the concentration of the virus remains low. But when the tick feeds, the TBEV titers raise to reach detectable levels.
  • A percentage (6%) of TBEV-infected adult castor bean ticks can navigate DEET-covered areas with a 1% formulation. In contrast, uninfected ticks were unable to cross these areas.

Takeaway

In general, ticks infected with TBEV demonstrated enhanced tick mobility, including walking speed and duration, and a proclivity toward higher questing heights. These changes may lead to greater outcomes when it comes to tick and microbe survivability.

Putting It All Together

There’s no doubt that’s an incredible amount of information to take it in. But this valuable data sets the stage for the urgent need for ongoing research when it comes to understanding how pathogens affect and modify tick behavior.

There is a wide array of tick species worldwide, and countless disease-causing pathogens that pose a threat to human health. Tracking behavioral changes in infected and non-infected ticks could one day lead to positive, new developments for halting the spread of tick-borne diseases.

In the meantime, your best bet is to practice good tick-prevention strategies like doing regular tick checks when coming in from the outdoors, wearing permethrin-treating shoes and clothing, and promptly removing attached ticks with a pair of fine-pointed tweezers. 

REFERENCES

1. Alberdi P, Espinosa PJ, Cabezas-Cruz A, de la Fuente J. Anaplasma phagocytophilum Manipulates Host Cell Apoptosis by Different Mechanisms to Establish Infection. Vet Sci. 2016;3(3):15. Published 2016 Jul 15. doi: 10.3390/vetsci3030015
2. Benelli G. Pathogens Manipulating Tick Behavior-Through a Glass, Darkly. Pathogens. 2020;9(8):E664. Published 2020 Aug 17. doi: 10.3390/pathogens9080664
3. Blisnick AA, Šimo L, Grillon C, et al. The Immunomodulatory Effect of IrSPI, a Tick Salivary Gland Serine Protease Inhibitor Involved in Ixodes ricinus Tick Feeding. Vaccines (Basel). 2019;7(4):148. Published 2019 Oct 12. doi: 10.3390/vaccines7040148
4. Carr AL, Mitchell RD III, Dhammi A, Bissinger BW, Sonenshine DE, Roe RM. Tick Haller’s Organ, a New Paradigm for Arthropod Olfaction: How Ticks Differ from Insects. Int J Mol Sci. 2017;18(7):1563. Published 2017 Jul 18. doi: 10.3390/ijms18071563
5. Dai J, Narasimhan S, Zhang L, Liu L, Wang P, Fikrig E. Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent. PLoS Pathog. 2010;6(11):e1001205. Published 2010 Nov 24. doi: 10.1371/journal.ppat.1001205
6. Lyme and Other Tickborne Diseases Increasing. Centers for Disease Control and Prevention website. https://www.cdc.gov/media/dpk/diseases-and-conditions/lyme-disease/index.html#:~:text=The%20reported%20numbers%20of%20cases,59%2C349%20reported%20cases%20in%202017.
7. Tick-borne encephalitis. Centers for Disease Control and Prevention website. https://wwwnc.cdc.gov/travel/diseases/tickborne-encephalitis#:~:text=Tick%2Dborne%20encephalitis%20(TBE),headache%2C%20nausea%2C%20and%20vomiting
_____________________
 
**Comment**
 
This explains a lot – if only mainstream medicine/research will listen instead of conducting more climate data. It also makes sense.
 
 
It is commonly known that parasites affect behavior:

Parasites are a whole new fantastical frontier. I’ll never forget this information on how parasites affect human behavior by Dr. Klinghardt, which I found here:  http://www.betterhealthguy.com/a-deep-look-beyond-lyme

  • Parasite patients often express the psyche of the parasites – sticky, clingy, impossible to tolerate – but a wonderful human being is behind all of that.

  • We are all a composite of many personalities. Chronic infections outnumber our own cells by 10:1. We are 90% “other” and 10% “us”. Our consciousness is a composite of 90% microbes and 10% us.

  • Our thinking, feeling, creativity, and expression are 90% from the microbes within us. Patients often think, crave, and behave as if they are the parasite.

  • Our thinking is shaded by the microbes thinking through us. The food choices, behavioral choices, and who we like is the thinking of the microbes within us expressing themselves.

  • Patients will reject all treatments that affect the issue that requires treating.

  • Patients will not guide themselves to health when the microbes have taken over.

It only follows that parasites will affect tick behavior as well.

Denmark Success With COVID With No Lockdown Or Masks. Tells Citizens the Truth About HCQ

https://principia-scientific.com/denmark-government-tells-citizens-the-truth-about-hcq/

Denmark: Government Tells Citizens The Truth About HCQ

Written by John O’Sullivan

We reported yesterday on the astonishing success of the no lockdown, no mask policy in Denmark, a nation which has not suffered the rampant number of deaths from COVID19 seen in politically-biased US cities such as New York. Below is the official statement from the Danish Government revealing the truth about hydroxychloroquine, regarded by many thousands of doctors worldwide as a “game changer” in defeating the pandemic.

The Danish Medicines Agency writes as follows:

COVID-19: Facts About Chloroquine And Hydroxychloroquine

07 April 2020

There are many rumours that hydroxychloroquine or chloroquine has a documented effect on COVID-19 and that other countries have approved it for COVID-19. Read the facts here.

Hydroxychloroquine is a medicine in tablet form authorised in the EU for the treatment of arthritis and skin diseases and for the prevention of malaria. The fact that the medicine is authorised means, in this context, that the authorities have granted a marketing authorisation to the company which manufactures the medicine. The marketing authorisation allows the company to sell the medicine for the treatment of precisely these diseases. The marketing authorisation has been granted based on documentation from the company that hydroxychloroquine is effective on these diseases and is safe to use. There is a medicine called chloroquine, and there is a medicine called hydroxychloroquine. Only hydroxychloroquine is sold in Denmark.

Since 23 March 2020, hydroxychloroquine in Denmark can only be prescribed by hospital doctors and specialist doctors for rheumatic disorders, skin diseases and childhood diseases as well as only be used in clinical trials. This means that Danish hospital doctors, for example in connection with research projects, have the possibility of testing if hydroxychloroquine has an effect in COVID-19 patients.

In principle, Danish hospital doctors are also allowed to use hydroxychloroquine to treat COVID-19 patients even if they are not enrolled in research projects. This is because doctors have the right to prescribe the medicine of their choice according to their assessment and under their own responsibility. [emphasis added to this key paragraph]

The Danish Medicines Agency cannot authorise hydroxychloroquine for COVID-19 if the company manufacturing the medicine does not apply for an authorisation. Marketing authorisations are granted based on the initiative of the company. In addition, marketing authorisations are based on documentation of efficacy and side effects, and more. Right now, only very few studies have been conducted to investigate the effect of chloroquine and hydroxychloroquine on COVID-19, and their total evidence base is not solid enough to assess if chloroquine or hydroxychloroquine has a real effect on COVID-19. Likewise, it has not been established what side effects the medicines could cause when used to treat COVID-19.

Other Countries’ Reports On Chloroquine And Hydroxychloroquine

Right now, there are many reports in the press and social media claiming that drug regulatory authorities in other countries have authorised chloroquine or hydroxychloroquine for the treatment of COVID-19. It is important to note that the authorities in other countries have not issued marketing authorisations that allow chloroquine or hydroxychloroquine to be marketed as a treatment for COVID-19. The case here is that doctors in other countries have been given possibilities to use the medicines to treat COVID-19 patients. Possibilities that are similar to those given to Danish hospital doctors.

USA’s Reports On Chloroquine And Hydroxychloroquine

The FDA has granted a special permission to use chloroquine and hydroxychloroquine in clinical trials and in emergency situations. This is not a genuine authorisation, but a possibility given to American doctors to use chloroquine in COVID-19 clinical trials and in the treatment of COVID-19 if the doctor has no other options.
See the FDA’s announcement here.

European Medicines Agency (EMA)

The EMA has announced that chloroquine and hydroxychloroquine should only be used for the treatment of COVID-19 in connection with clinical trials or in national emergency use programmes for the treatment of critically ill COVID-19 patients. Denmark is thus in line with the recommendations from the European Medicines Agency, offering the same possibilities to use hydroxychloroquine in clinical trials and allowing hospital doctors to prescribe it. See the EMA’s announcement here.

The Authorisation In Poland

Poland is the only country to have actually authorised a chloroquine-containing product for supportive treatment of COVID-19. The product concerned is produced locally and called Arachin. It is manufactured by the Polish company Adamed Pharma. The Danish Medicines Agency has not seen the Polish company’s authorisation basis, and the drug regulatory authorities in Poland have informed us that use of the product is only permitted in hospitals in Poland. Denmark can neither assess nor issue a marketing authorisation for a Polish product if the Polish company has not submitted an application to the Danish Medicines Agency with the intent of putting it on the Danish market. See Poland’s announcement here.

The Danish Medicines Agency has also investigated how several other European countries like the UK, Spain and Belgium have approached the question of hydroxychloroquine and COVID-19. Several other European countries have also emphasised that hydroxychloroquine is not authorised for COVID-19, and that there is presently no evidence of the treatment. Several countries have announced that they indeed prefer the treatment to be conducted as part of clinical trials.

The Danish Medicines Agency is following international research closely. At present, there are not enough scientific studies to draw any conclusions on the effect of chloroquine and hydroxychloroquine on COVID-19.

Danish Medicines Agency

Axel Heides Gade 1

2300 København S

Email: dkma@dkma.dk

Read more at laegemiddelstyrelsen.dk

***

About the author: John O’Sullivan John is CEO and co-founder (with Dr Tim Ball) of Principia Scientific International (PSI).  John is a seasoned science writer and legal analyst who assisted Dr Ball in defeating world leading climate expert, Michael ‘hockey stick’ Mann in the ‘science trial of the century‘. O’Sullivan is credited as the visionary who formed the original ‘Slayers’ group of scientists in 2010 who then collaborated in creating the world’s first full-volume debunk of the greenhouse gas theory plus their new follow-up book.

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

______________________

**Comment**

There is much evidence that HCQ works on certain COVID patients, particularly early on with the addition of zinc and azithromycin.  There have been numerous attempts to discredit it, which has resulted in doctors speaking out worldwide on how these studies had HUGE design flaws which rigged a poor outcome:  https://madisonarealymesupportgroup.com/2020/06/30/dr-meryl-nass-discovers-hydroxychloroquine-experiments-were-designed-to-kill-covid-patients-how-many-were-murdered/

BTW: the mainstream media is complicit in all of this because they’ve been bought and paid for by Bill Gates:  https://madisonarealymesupportgroup.com/2020/08/29/every-breath-you-take-every-move-you-make-the-who-is-watching-you-the-media-is-bought-out-by-gates/  Why support an effective, cheap drug when you can make billions off of an experimental vaccine and the expensive anti-viral Remdesivir ‘authorities’ serve to profit from (even though it’s not backed by results)? https://madisonarealymesupportgroup.com/2020/07/02/remdesivir-for-covid-19-not-backed-by-results/

For more:  https://madisonarealymesupportgroup.com/2020/07/20/how-a-false-hydroxychloroquine-narrative-was-created/

https://madisonarealymesupportgroup.com/2020/08/11/yale-epidemiologist-dr-fauci-running-misinformation-campaign-against-hydroxychloroquine-aap-says-fda-caused-20000-deaths/

https://madisonarealymesupportgroup.com/2020/06/16/aaps-sues-fda-for-irrational-interference-of-access-to-life-saving-hydroxychloroquine/

https://madisonarealymesupportgroup.com/2020/08/08/new-report-turkeys-use-of-hcq-early-saves-lives-fauci-should-be-in-jail/

https://madisonarealymesupportgroup.com/2020/08/12/more-doctors-speak-out-on-censorship-and-mass-murderer-anthony-faucis-false-information-regarding-hydroxychloroquine/

 

Operation Moonshot: What Do the Leaked Documents Say? UK Government Faces Legal Action

https://www.bmj.com/content/370/bmj.m3558


Operation Moonshot: What do the leaked documents say?

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3558 (Published 11 September 2020)Cite this as: BMJ 2020;370:m3558

  1. Elisabeth Mahase

Operation Moonshot is the name of the UK government’s newly proposed covid-19 mass testing scheme. The plan, revealed by The BMJ,1 involves an expansion of testing from the current hundreds of thousands of tests each day to 10 million a day by early 2021. But how does the government propose to do this?

How will testing increase between now and early 2021?

The documents show a proposed three stage rollout. They state that the UK will carry out between 200, 000 to 800, 000 tests a day between September and December 2020. This might break down to:

  • 200, 000 tests a day on people with symptoms,

  • 100, 000 a day on people without symptoms in local areas to suppress outbreaks,

  • 250, 000 a day on people without symptoms in the NHS and care homes, and

  • 100 000 a day through national prevalence studies.

The plan then states that there would be “full rollout” in early 2021 to 10 million tests a day, to “enable people to return to and maintain normal life.” At this stage, weekly testing would be made available progressively to the whole population to allow people to go to high risk events by using a “digital passport” to show they have tested negative for the virus.

How will testing capacity be increased?

The documents talk about “buying large scale capabilities” from partners such as the drug company GSK to “build a large scale testing organisation.” However, under “potential partners for increasing laboratory capacity” the documents list only the company AstraZeneca. Under logistics and warehousing, the documents list potential partners as Boots, Sainsbury’s, DHL, Kuehne+Nagel, G4S, and Serco. Under workforce are listed universities, the Society of Microbiologists, and the British Society of Immunology.

Alongside mainly commercial partnerships, the documents also state that a number of new tests and technologies would need to be used, including some that do not yet exist.

“Delivering testing at the scale and level of ambition set by the prime minister is likely to mean developing, validating, procuring, and operationalising testing technology that currently does not exist,” the plans state. Lower sensitivity testing for “screening/enabling purposes” could also be used, with polymerase chain reaction (PCR) testing then used to “confirm positive results or in situations where accuracy is needed for highest risk individuals.”

Testing technology listed in the documents includes qrt-PCR, Endpoint PCR, LAMP, LamPORE, lateral flow antigen test, and whole genome sequencing. Two of these tests—lateral flow antigen tests and LAMP—are listed as having a “lower sensitivity” of between 80% and 100%.

Where will people get tested?

The documents propose venues such as general practices and pharmacies, workplaces and schools, and community based local testing sites.2 Testing may also be carried out on site at events before people can enter.

Are there any plans to get the public on board?

The documents show that there have been discussions over how to incentivise people to be tested. They point to enforcing testing “via a sanction-based model” or through “offering individuals opportunities/access from being tested,” such as being able to attend events.

What is a digital passport?

Testing for access to certain spaces features heavily in the documents, with reference to “immunity/virus free passports,” likely to be available through an app. The plans say that testing could be used to “give people assurance that, at least for a limited time, they are unlikely to have the virus and are at low risk of transmitting it to others.”

They say, “A negative test result (or potentially a positive antibody result) may inform not just whether you could attend an in-patient appointment, but if you go to work that day, access a venue, get on a flight or visit an elderly relative.” The documents also point to a “significant expansion” of testing funded and delivered by the private sector, such as in football stadiums to allow access.

Do the documents acknowledge any concerns?

Yes, although not in great detail. In reference to the non-PCR tests, it is repeatedly noted that “new types of test are likely to be less accurate [than PCR], introducing some level of risk.” In terms of how testing would affect behaviour, the documents say that regular testing “might make people behave in safer ways, by building covid-safe routines into their daily lives, or less safely by giving false a degree of comfort.”

However, the documents also say, “We will need to take some risks, experiment and evaluate carefully, and find out what works and what does not.”

How will the £100bn be spent?

This figure is mentioned only briefly in the documents. They state that “opening up the economy” and allowing the population to “return to something closer to normality” would cost “over £100bn to deliver.” The figure is not broken down.

What reason does the government give for Moonshot?

The documents state that the objective of the mass testing programme is to “utilise the full range of testing approaches and technologies to help reduce the R rate, keep the economy open and enable a return to normal life.” They say that Moonshot has been described by the prime minister as the “only hope for avoiding a second national lockdown before a vaccine, something that the country cannot afford.”

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

References

  1. ↵
  2. ↵

_________________________

**Comment**

There are a number of problems with this, including the fact ALL testing for COVID is abysmal – particularly but not limited to the PCR:  https://madisonarealymesupportgroup.com/2020/05/13/president-of-tanzania-punks-who-sending-samples-of-fruit-goats-sheep-even-motor-oil-for-covid-testing-nearly-half-come-back-positive/

I’m skeptical that a PRC test is ever true. It’s a great scientific research tool. It’s a horrible tool for clinical medicine.30% of your infected cells have been killed before you show symptoms. By the time you show symptoms…the dead cells are generating the symptoms.” Dr. David Rasnick, bio-chemist, protease developer, and former founder of an EM lab called Viral Forensics

https://madisonarealymesupportgroup.com/2020/08/09/gov-mike-dewine-of-ohio-tests-positive-then-negative-for-coronavirus/

Viral cultures for COVID-19 infectivity assessment. Systematic review. Tom Jefferson, Elizabeth Spencer, Jon Brassey, Carl Heneghan medRxiv 2020.08.04.20167932; doi: https://doi.org/10.1101/2020.08.04.20167932

The authors reviewed 14 studies that they labeled of “moderate quality” due to being inadequately sized, lack of protocols, standardized methods and reporting and reporting bias. They hit on some interesting issues like time of testing in relation to symptom severity, viral shedding, etc.  They also pointed out that time of testing is important because:

The lower the cycle threshold level the greater the amount of RNA (genetic material) there is in the sample. The higher the cycle number, the less RNA there is in the sample.

What does this mean?

This detection problem is ubiquitous for RNA viruses detection. SARS-CoV, MERS, Influenza Ebola and Zika viral RNA can be detected long after the disappearance of the infectious virus.

In other words, the test is picking up RNA material but the patient isn’t infected any more.The authors point out that this material can linger for weeks in the body.

And the most important point:

IF THIS IS NOT UNDERSTOOD, PCR RESULTS MAY LEAD TO RESTRICTIONS FOR LARGE GROUPS OF PEOPLE WHO DO NOT PRESENT AN INFECTION RISK.

The UK government faces legal action

https://www.theguardian.com/uk-news/2020/sep/18/government-faces-legal-action-over-moonshot-covid-testing-project  (Article within link)

Excerpt:

The health secretary, Matt Hancock, and the minister for the Cabinet Office, Michael Gove, are named in a case that alleges the project, as described in leaked papers, is unlawful because it ignores scientific evidence, involves potentially huge private contracts that may not have been tendered and breaks the government’s own value-for-money rules.

The group behind this legal action is the Good Law Project which wants a judicial review of the moonshot plan and states that it should have consulted the National Screening Committee first. There’s also concern over the vast sum of public money, without transparency and public input, involved for technology that doesn’t even exist.  It also states he leaked document reveals the following as potential key partners in the project:

  • the accountancy firm Deloitte
  • G4S
  • Serco
  • Boots
  • Sainsbury’s
  • AstraZeneca
  • GSK and Smith and Nephew.

 

 

Coronavirus Cases, Hospitalizations Soar in Hawaii Since Indoor and Outdoor Mask Mandates

https://www.theblaze.com/conservative-review/horowitz-coronavirus-cases-hospitalizations-soar-hawaii-since-indoor-outdoor-mask-mandates

At what point do results and outcomes begin to matter? On the current political trajectory, we will be stripped of our humanity and forced to wear face burkas indefinitely without any debate, votes, benchmarks, or transparency. Not only are there no randomized clinical trials showing evidence that mask-wearing in the general populace works to stop the spread of respiratory viruses, but the reality of these mandates in practice for the past few months shows they are worthless and that the virus spreads as it spreads, regardless of human input. The latest example is Hawaii.  (See link for article)

______________________

**Comment**

Nothing like good old, simple observational science.  It’s interesting that Fauci, a huge fan of randomized controlled trials, states there are no plans to conduct a RCT on the effectiveness of universal ask-wearing.  Huh.  Perhaps he already knows they are worthless. The CDC since as late as May is citing the 10 randomized controlled trials that showed:

“no significant reduction in influenza transmission with the use of face masks.”

Horowitz’s article shows that Hawaii, the Philippines, and Peru all with universal mask mandates have some of the highest COVID case counts, hospitalizations, and death rates per capita in the world.

Hello, anybody home?

Again, public officials and mainstream medicine should be educating the public on how to make yourself a tough target for viruses and disease.  But that wouldn’t benefit Big Pharma and other spin-doctors who wouldn’t get kickbacks from things like vitamin C, D, zinc, healthy diet, lowering stress, and cheap drugs like the MATH+ protocol, Ivermectin, HCQ, heparin, and azithromycin.  Sigh, welcome to the new normal.

For more on the ineffectiveness of masks:  https://madisonarealymesupportgroup.com/2020/08/13/best-video-on-masks-yet-new-health-problems-emerging-from-continuous-mask-wearing-but-attempted-murder-charges-sought-for-those-who-refuse-them/

https://madisonarealymesupportgroup.com/2020/08/17/ppe-developer-on-n95-masks-70-of-what-you-breathe-is-not-filtered/

https://madisonarealymesupportgroup.com/2020/08/23/covid-19-important-potential-side-effects-of-wearing-face-masks-that-we-should-bear-in-mind/

Yet, here’s our ‘authorities’, despite scientific evidence, flip flopping like a waffle-maker on masks:

http://\

“No, yes, no, yes…..”

 

Yes, Fauci and Gates Do Have Ties to COVID-19 Vaccine Maker

https://www.jeremyrhammond.com/2020/09/16/fauci-gates-moderna/

by Sep 16, 2020

Bill Gates with NIH Director Francis Collins and NIAID Director Anthony Fauci at the NIH in June 2017 (Photo by NIH, licensed under CC BY-NC 2.0)
A USA Today headline falsely claiming Anthony Fauci and Bill Gates have “no ties” to Moderna is illustrative of a major problem with our media.

On September 11, USA Today published an article with a headline declaring, “Fact check: Fauci, Gates, Epstein and Soros have no ties to drug company Moderna”.

But that headline was false.

Both Anthony Fauci, the director of the National Institute for Allergy and Infectious Disease (NIAID) and member of the White House coronavirus task force, and Bill Gates do have ties to Moderna, a pharmaceutical company developing a COVID-19 vaccine using mRNA technology.

The article does rightly identify misinformation presented in a video widely shared on social media.

With respect to Fauci, USA Today notes that the video’s claim that Fauci was the first CEO of Moderna is false. Nevertheless, Fauci does have ties to Moderna.

Similarly, the article notes that the video’s claim that Fauci and Gates were college roommates is false. But Gates, too, nevertheless does have direct ties to Moderna.  (See article for link)

____________________

**Comment**

Mainstream media is worthless, and completely bought and sold to the highest bidder:  https://madisonarealymesupportgroup.com/2020/05/20/how-bill-gates-controls-global-messaging-and-censorship/

https://madisonarealymesupportgroup.com/2020/08/29/every-breath-you-take-every-move-you-make-the-who-is-watching-you-the-media-is-bought-out-by-gates/

https://madisonarealymesupportgroup.com/2020/07/25/anti-vax-labelling-and-the-mainstream-media-who-is-coordinating-this/

https://madisonarealymesupportgroup.com/2020/07/26/2011-article-does-gates-funding-of-media-taint-objectivity/?

Let’s review the facts:

  1. Moderna’s listing the Bill & Melinda Gates Foundation as a “strategic collaborator”, to advance mRNA-based development projects.
  2. A 2019 Shareholder Letter under “Partnerships”, shows $187 million in grants from the Biomedical Advanced Research and Development Authority (BARDA, which operates under DHS), Defense Advanced Research Projects Agency (DARPA, an agency of the DOD), and the Bill and Melinda Gates Foundation.
  3. Fauci, head of NIAID, which operates under the NIH and has announced the beginning of a phase one clinical trial for Moderna’s COVID-19 vaccine, is also funding the trial.  NIAID scientists and collaborators at Moderna also developed it.

Please read Hammond’s article in full as he presents so many different cases of media bias.  He contacted the author of the USA Today article and exposed the inaccuracies.  In the end, they finally changed the title to better reflect the content.  He goes into the whole weaponization of “fake news” and the fact the supposed “fact checkers” are continually caught in falsehoods.

Hammond plainly states that the media is being used to “manufacture consent for extreme and harmful ‘lockdown’ measures in response to the SARS-CoV-2 pandemic and for vaccine mandates.”

He aptly reminds us that it’s up to US to hold the media accountable AND to fight against this authoritarian agenda.